IdentificationGeneric Name(2s,3r)-3-Amino-2-Hydroxy-5-(Ethylsulfanyl)Pentanoyl-((S)-(-)-(1-Naphthyl)Ethyl)AmideDrugBank Accession NumberDB04108BackgroundNot AvailableTypeSmall MoleculeGroupsExperimentalStructure


3DDownload MOLSDF3D-SDFPDBSMILESInChI


 Similar StructuresStructure for (2s,3r)-3-Amino-2-Hydroxy-5-(Ethylsulfanyl)Pentanoyl-((S)-(-)-(1-Naphthyl)Ethyl)Amide (DB04108)× CloseWeightAverage: 346.487 Monoisotopic: 346.171498776 Chemical FormulaC19H26N2O2SSynonymsNot AvailablePharmacologyIndicationNot AvailableReduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.See how  Build, train, & validate predictive machine-learning models with structured datasets.See howContraindications & Blackbox WarningsAvoid life-threatening adverse drug eventsImprove clinical decision support with information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Learn more  Avoid life-threatening adverse drug events & improve clinical decision support.Learn morePharmacodynamicsNot AvailableMechanism of actionTargetActionsOrganismUMethionine aminopeptidase 2Not AvailableHumansAbsorptionNot AvailableVolume of distributionNot AvailableProtein bindingNot AvailableMetabolismNot AvailableRoute of eliminationNot AvailableHalf-lifeNot AvailableClearanceNot AvailableAdverse EffectsImprove decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates.Learn more  Improve decision support & research outcomes with our structured adverse effects data.Learn moreToxicityNot AvailablePathwaysNot AvailablePharmacogenomic Effects/ADRs 


Not AvailableInteractionsDrug Interactions 


This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist. Not AvailableFood InteractionsNot AvailableCategoriesDrug CategoriesNot AvailableChemical TaxonomyProvided by ClassyfireDescriptionThis compound belongs to the class of organic compounds known as beta amino acids and derivatives. These are amino acids having a (-NH2) group attached to the beta carbon atom.KingdomOrganic compoundsSuper ClassOrganic acids and derivativesClassCarboxylic acids and derivativesSub ClassAmino acids, peptides, and analoguesDirect ParentBeta amino acids and derivativesAlternative ParentsNaphthalenes / N-acyl amines / Monosaccharides / Secondary carboxylic acid amides / Secondary alcohols / Sulfenyl compounds / Dialkylthioethers / Organopnictogen compounds / Organic oxides / Monoalkylamines / Hydrocarbon derivatives / Carbonyl compounds


 show 2 moreSubstituentsAlcohol / Amine / Aromatic homopolycyclic compound / Benzenoid / Beta amino acid or derivatives / Carbonyl group / Carboxamide group / Dialkylthioether / Fatty acyl / Fatty amide / Hydrocarbon derivative / Monosaccharide / N-acyl-amine / Naphthalene / Organic nitrogen compound / Organic oxide / Organic oxygen compound / Organonitrogen compound / Organooxygen compound / Organopnictogen compound / Organosulfur compound / Primary aliphatic amine / Primary amine / Secondary alcohol / Secondary carboxylic acid amide / Sulfenyl compound / Thioether


 show 17 moreMolecular FrameworkAromatic homopolycyclic compoundsExternal DescriptorsNot AvailableAffected organismsNot AvailableChemical IdentifiersUNIINot AvailableCAS numberNot AvailableInChI KeyAIIOXZPEXXZCML-KKXDTOCCSA-NInChIInChI=1S/C19H26N2O2S/c1-3-24-12-11-17(20)18(22)19(23)21-13(2)15-10-6-8-14-7-4-5-9-16(14)15/h4-10,13,17-18,22H,3,11-12,20H2,1-2H3,(H,21,23)/t13-,17-,18-/m0/s1IUPAC Name(2S,3S)-3-amino-5-(ethylsulfanyl)-2-hydroxy-N-[(1S)-1-(naphthalen-1-yl)ethyl]pentanamideSMILES[H][C@](N)(CCSCC)[C@]([H])(O)C(=O)N[C@@]([H])(C)C1=C2C=CC=CC2=CC=C1ReferencesGeneral ReferencesNot AvailableExternal LinksPubChem Compound5287684PubChem Substance46508224ChemSpider4450002ZINCZINC000012504146PDBe LigandAO1PDB Entries1r5gClinical TrialsClinical Trials 


PhaseStatusPurposeConditionsCountPharmacoeconomicsManufacturersNot AvailablePackagersNot AvailableDosage FormsNot AvailablePricesNot AvailablePatentsNot AvailablePropertiesStateSolidExperimental PropertiesNot AvailablePredicted PropertiesPropertyValueSourceWater Solubility0.00918 mg/mLALOGPSlogP2.55ALOGPSlogP2.24ChemaxonlogS-4.6ALOGPSpKa (Strongest Acidic)12.57ChemaxonpKa (Strongest Basic)8.75ChemaxonPhysiological Charge1ChemaxonHydrogen Acceptor Count3ChemaxonHydrogen Donor Count3ChemaxonPolar Surface Area75.35 Å2ChemaxonRotatable Bond Count8ChemaxonRefractivity100.55 m3·mol-1ChemaxonPolarizability38.96 Å3ChemaxonNumber of Rings2ChemaxonBioavailability1ChemaxonRule of FiveYesChemaxonGhose FilterYesChemaxonVeber's RuleNoChemaxonMDDR-like RuleNoChemaxonPredicted ADMET FeaturesPropertyValueProbabilityHuman Intestinal Absorption+0.9961Blood Brain Barrier+0.6308Caco-2 permeable-0.622P-glycoprotein substrateSubstrate0.788P-glycoprotein inhibitor INon-inhibitor0.8056P-glycoprotein inhibitor IINon-inhibitor0.841Renal organic cation transporterNon-inhibitor0.8616CYP450 2C9 substrateNon-substrate0.7859CYP450 2D6 substrateNon-substrate0.6918CYP450 3A4 substrateNon-substrate0.5CYP450 1A2 substrateInhibitor0.5101CYP450 2C9 inhibitorNon-inhibitor0.8022CYP450 2D6 inhibitorNon-inhibitor0.6743CYP450 2C19 inhibitorNon-inhibitor0.6996CYP450 3A4 inhibitorNon-inhibitor0.6842CYP450 inhibitory promiscuityLow CYP Inhibitory Promiscuity0.5773Ames testNon AMES toxic0.6518CarcinogenicityNon-carcinogens0.8803BiodegradationNot ready biodegradable0.9876Rat acute toxicity2.3330 LD50, mol/kg Not applicablehERG inhibition (predictor I)Weak inhibitor0.9917hERG inhibition (predictor II)Inhibitor0.7547  ADMET data is predicted using admetSAR, a free tool for evaluating chemical ADMET properties. (23092397) SpectraMass Spec (NIST)Not AvailableSpectraSpectrumSpectrum TypeSplash KeyPredicted GC-MS Spectrum - GC-MSPredicted GC-MSNot AvailablePredicted MS/MS Spectrum - 10V, Positive (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 20V, Positive (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 40V, Positive (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 10V, Negative (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 20V, Negative (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 40V, Negative (Annotated)Predicted LC-MS/MSNot AvailableTargetsBuild, predict & validate machine-learning modelsUse our structured and evidence-based datasets to unlock newinsights and accelerate drug research.Learn more  Use our structured and evidence-based datasets to unlock new insights and accelerate drug research.Learn moreBinding Properties×PropertyMeasurementpHTemperature (°C)ReferencesIC 50 (nM)227.422A30235IC 50 (nM)30N/AN/AA30103


 Details


 Binding Properties1. Methionine aminopeptidase 2KindProteinOrganismHumansPharmacological actionUnknownGeneral FunctionPoly(a) rna bindingSpecific FunctionCotranslationally removes the N-terminal methionine from nascent proteins. The N-terminal methionine is often cleaved when the second residue in the primary sequence is small and uncharged (Met-Ala...Gene NameMETAP2Uniprot IDP50579Uniprot NameMethionine aminopeptidase 2Molecular Weight52891.145 DaReferencesOverington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. [Article] Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. [Article] Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. [Article] ×Identify potential medication risksEasily compare up to 40 drugs with our drug interaction checker.Get severity rating, description, and management advice. Learn more   Drug created at June 13, 2005 13:24 / Updated at June 12, 2020 16:52 